Publications by authors named "Helene Zephir"

Claim this Profile
L
Life-threatening immune-related adverse events in the intensive care unit: a narrative review.
Samuel Pichon, Ghadi Zebian, Côme Bureau, Clémentine Levy, Charlotte Lacombe, Helene Zephir

Intensive Care Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients.
Chloé Comet, Guillaume Jouvenot, Bertrand Bourre, Jonathan Ciron, Bertrand Audoin

Mult Scler· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.
Antoine Gavoille, Fabien Rollot, Romain Casey, Guillaume Mathey, Emmanuelle Le Page, Hélène Zephir

JAMA Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.
Marine Perriguey, Camille Rigollet, Sean A Freeman, Lisa Graille-Avy, Jean-Christophe Lafontaine

Neurotherapeutics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France.
Sarah Wilson, Emmanuelle Leray, Floriane Calocer, Fabien Rollot, Mathieu Fauvernier, Hélène Zephir

BMC Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.
Antoine Gavoille, Mikail Nourredine, Fabien Rollot, Romain Casey, Guillaume Mathey, Helene Zephir

J Neurol Neurosurg Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.
Camille Robin, Fabien Rollot, Mathilde Lefort, Romain Casey, Sandra Vukusic, Helene Zephir

Neurology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.
Antoine Gavoille, Emmanuelle Leray, Romain Marignier, Fabien Rollot, Romain Casey, Helene Zephir

Neurology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network.
Johannes Lorscheider, Alessio Signori, Suvitha Subramaniam, Pascal Benkert, Sandra Vukusic, Helene Zephir

J Neurol Neurosurg Psychiatry· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolution.
Stéphane Rodriguez, Laura Couloume, Juliette Ferrant, Nicolas Vince, Marion Mandon, Helene Zephir

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study.
Mikael Cohen, Fabien Rollot, Marc Debouverie, Hélène Zephir, Sandra Vukusic

Eur J Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in France.
Jérôme de Sèze, Pierre Labauge, Roland Liblau, Mikel Martinez, Thibault Moreau, Helene Zephir

Adv Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.
Camille Rigollet, Sean A Freeman, Marine Perriguey, Jan-Patrick Stellmann, Lisa Graille-Avy

Neurotherapeutics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC study.
Ryan Ramdani, Julie Pique, Romain Deschamps, Jonathan Ciron, Elisabeth Maillart, Hélène Zephir

Mult Scler· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.
Marie Mainguy, Romain Casey, Sandra Vukusic, Christine Lebrun-Frenay, Eric Berger, Helene Zephir

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GAD Antibodies as an Etiology of Cerebral Cortical Encephalitis: 2 Case Reports.
Bruno Lemarchant, Cristina Birzu, Louis Cousyn, Stéphanie Rogeau, Delphine Leclercq

Eur J Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population.
Elisabeth Maillart, Fabien Rollot, Emmanuelle Leray, Lakhdar Benyahya, Bertrand Bourre

Mult Scler· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS.
Françoise Durand-Dubief, Natalia Shor, Bertrand Audoin, Bertrand Bourre, Mickael Cohen, Hélène Zephir

J Neuroradiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between education level and disability progression in patients with multiple sclerosis in France.
Mathilde Lefort, Olivier Dejardin, Eric Berger, Jean-Philippe Camdessanché, Jonathan Ciron, Hélène Zephir

Mult Scler· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France.
Mathilde Lefort, Olivier Dejardin, Eric Berger, Jean-Philippe Camdessanché, Jonathan Ciron, Hélène Zephir

Mult Scler· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations.
Romain Deschamps, Caroline Papeix, Xavier Ayrignac, Bertrand Bourre, Jonathan Ciron

Rev Neurol (Paris)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study.
Marion Hay, Fabien Rollot, Romain Casey, Anne Kerbrat, Gilles Edan

Neurology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndrome.
Cassandre Landes-Château, Vito Ag Ricigliano, Lydiane Mondot, Eric Thouvenot, Pierre Labauge

Mult Scler· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
Antoine Gavoille, Fabien Rollot, Romain Casey, Anne Kerbrat, Emmanuelle Le Page, Hélène Zephir

JAMA Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study.
Romain Deschamps, Jessica Guillaume, Jonathan Ciron, Bertrand Audoin, Aurélie Ruet, Helene Zephir

Neurology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis